http://www.legislation.gov.uk/id/uksi/2012/1916/schedule/12A

SCHEDULES

F1SCHEDULE 12AFurther provision as to the performance of pharmacovigilance activities

Annotations:

Amendments (Textual)

F1

Sch. 12A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 6 (as amended by S.I. 2019/1385, reg. 1, Sch. 1 para. 9 and S.I. 2020/1488, reg. 1, Sch. 2 para. 192); 2020 c. 1, Sch. 5 para. 1(1)

PART 2Minimum requirements for the quality systems for the performance of pharmacovigilance activities by the licensing authority and holders

Performance indicators9

1

The holder and the licensing authority may use performance indicators to continuously monitor the good performance of pharmacovigilance activities.

2

The licensing authority may publish a list of performance indicators.